Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate.
Authors : Bellamy L L; Rosencher N N; Eriksson Bi B;
Affiliations : Anaesthesiology Department, Hôpital Cochin (AP-HP), René Descartes University, Paris 75014 France;
Journal : Patient Prefer Adherence (2009)
Related Links: Pubmed | Publisher website N/A
Prevention of venous thromboembolism with an oral Factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).
Authors : Eriksson B I BI; Turpie A G G AG; Lassen M R MR; Prins M H MH; Agnelli G G; Kälebo P P; Wetherill G G; Wilpshaar J W JW; Meems L L; ;
Affiliations : Department of Orthopaedics, Sahlgrenska University Hospital, Gothenburg, Sweden.
Journal : N/A (2010)
Related Links: Pubmed | Publisher website
Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
Authors : Wolzt M; Eriksson UG; Gouya G; Leuchten N; Kapiotis S; Elg M; Schützer KM; Zetterstrand S; Holmberg M;
Affiliations : Department of Clinical Pharmacology, Medical University of Vienna, Austria Corresponding author at: Universitätsklinik für Klinische Pharmakologie, Allgemeines Krankenhaus Wien, Währinger Gürtel 18–20, A-1090 Vienna, Austria. Tel.: +43 1 40400 2981; fax: +43 1 40400 2998
Journal : Thrombosis Research (2011)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...